Lymphoma

Oncology·MeSH: Lymphoma, T-Cell, Peripheral

Prevalence

56.0 / 100K

Incidence

19.6 / 100K/yr

668 drugs in development·118 companies·58 clinical trials

Drug Pipeline by Phase

Approved(31)

Drug	Company
Alimta®	ELI LILLY & Co (LLY)
belrapzo	EAGLE PHARMACEUTICALS, INC. (EGRX)
bexarotene	ANI PHARMACEUTICALS INC (ANIP)
bortezomib	Aptinyx Inc. (APTX)
bortezomib	MAIA Biotechnology, Inc. (MAIA)
bortezomib	Mersana Therapeutics, Inc. (MRSN)
bortezomib	DR REDDYS LABORATORIES LTD (RDY)
brilinta	ASTRAZENECA PLC (AZN)
carmustine	Amneal Pharmaceuticals, Inc. (AMRX)
cyclophosphamide	NEXUS BIOPHARMA INC (NEXS)
doxorubicin	Amneal Pharmaceuticals, Inc. (AMRX)
istodax	BRISTOL MYERS SQUIBB CO (BMY)
jaypirca	LOXO ONCOLOGY, INC. (LOXO)
Jaypirca	ELI LILLY & Co (LLY)
Jaypirca®	ELI LILLY & Co (LLY)
kymriah	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
lorbrena	PFIZER INC (PFE)
LYMPHIR	CITIUS ONCOLOGY, INC. (CTOR)
LYMPHIR	Citius Pharmaceuticals, Inc. (CTXR)
LYMPHIR (denileukin diftitox-cdxl)	CITIUS ONCOLOGY, INC. (CTOR)
methotrexate	ELITE PHARMACEUTICALS INC /NV/ (ELTP)
Monjuvi	Xencor Inc (XNCR)
nelarabine	Amneal Pharmaceuticals, Inc. (AMRX)
nelarabine	NEXUS BIOPHARMA INC (NEXS)
Rylaze / Enrylaze	Jazz Pharmaceuticals plc (JAZZ)
triamcinolone acetonide	Teva Pharmaceutical Industries Limited (TEVA)
Tyvyt	ELI LILLY & Co (LLY)
Tyvyt®	ELI LILLY & Co (LLY)
venetoclax	DR REDDYS LABORATORIES LTD (RDY)
xpovio	Karyopharm Therapeutics Inc. (KPTI)
ZYNLONTA (loncastuximab tesirine)	ADC Therapeutics SA (ADCT)

Phase 3(178)

Drug	Company
Abatacept	ENANTA PHARMACEUTICALS INC (ENTA)
Acalabrutinib	Merus N.V. (MRUS)
Adavosertib	ENANTA PHARMACEUTICALS INC (ENTA)
Afatinib	Relay Therapeutics, Inc. (RLAY)
Afatinib Dimaleate	Relay Therapeutics, Inc. (RLAY)
aNK	ImmunityBio, Inc. (IBRX)
axicabtagene ciloleucel	Lyell Immunopharma, Inc. (LYEL)
axicabtagene ciloleucel	GILEAD SCIENCES, INC. (GILD)
AZD0486	ASTRAZENECA PLC (AZN)
AZD0486 IV	ASTRAZENECA PLC (AZN)
azd3470	ASTRAZENECA PLC (AZN)
AZD4512	ASTRAZENECA PLC (AZN)
BEACOPPesc	Merus N.V. (MRUS)
BEACOPPesc - ABVD - PET2	Merus N.V. (MRUS)
bendamustin	GH Research PLC (GHRS)
bendamustine	GH Research PLC (GHRS)
bendamustine	Genmab A/S (GMAB)
bendamustine	BeOne Medicines Ltd. (ONC)
bendamustine	GENMAB A/S (GNMSF)
bendamustine	West Pharmaceutical Services Inc. (WST)
bendamustine	REGENERON PHARMACEUTICALS, INC. (REGN)
bendamustine	BeOne Medicines Ltd. (ONC)
Bendamustine	ENANTA PHARMACEUTICALS INC (ENTA)
Bendamustine	BeOne Medicines Ltd. (ONC)
Bendamustine	CYTOKINETICS INC (CYTK)
Bendamustine	ASTRAZENECA PLC (AZN)
Bendamustine	Merus N.V. (MRUS)
Bendamustine Hydrochloride	Merus N.V. (MRUS)
Bendamustine Hydrochloride	Filana Therapeutics Inc. (FLNA)
BGB-16673	Merus N.V. (MRUS)
BGB-16673	ENANTA PHARMACEUTICALS INC (ENTA)
bgb-21447	BeOne Medicines Ltd. (ONC)
bleomycin	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
bleomycin	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
Bleomycin	Structure Therapeutics Inc. (GPCR)
Bleomycin Sulfate	Cosmos Health Inc. (COSM)
Bleomycin Sulfate	Filana Therapeutics Inc. (FLNA)
Bleomycin Sulfate	PTC THERAPEUTICS, INC. (PTCT)
brentuximab vedotin	Merck & Co., Inc. (MRK)
Brentuximab vedotin	Structure Therapeutics Inc. (GPCR)
Brentuximab Vedotin	AXIM BIOTECHNOLOGIES, INC. (AXIM)
Brentuximab Vedotin	Cosmos Health Inc. (COSM)
Capivasertib	ENANTA PHARMACEUTICALS INC (ENTA)
cemacabtagene ansegedleucel (cema-cel)	Allogene Therapeutics, Inc. (ALLO)
chemotherapy agents	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
CHOP	Filana Therapeutics Inc. (FLNA)
cop	GH Research PLC (GHRS)
ctl019	Novartis AG (NVS)
CTL019	Novartis AG (NVS)
Dacarbazine	Cosmos Health Inc. (COSM)
Dacarbazine	Structure Therapeutics Inc. (GPCR)
Dacarbazine	AXIM BIOTECHNOLOGIES, INC. (AXIM)
Duvelisib	Merus N.V. (MRUS)
EGFR-TKI inhibitor based on investigator's choice	ADMA BIOLOGICS, INC. (ADMA)
epcoritamab	GH Research PLC (GHRS)
Etoposide	PTC THERAPEUTICS, INC. (PTCT)
Etoposide	AXIM BIOTECHNOLOGIES, INC. (AXIM)
Etoposide	Cosmos Health Inc. (COSM)
Etoposide Phosphate	AXIM BIOTECHNOLOGIES, INC. (AXIM)
Etoposide Phosphate	Cosmos Health Inc. (COSM)
Etoposide Phosphate	PTC THERAPEUTICS, INC. (PTCT)
filgrastim	GH Research PLC (GHRS)
Fludarabine	BRISTOL MYERS SQUIBB CO (BMY)
Fludarabine Injection	Filana Therapeutics Inc. (FLNA)
fludarabine phosphate	Filana Therapeutics Inc. (FLNA)
Futibatinib	Merck & Co., Inc. (MRK)
Futibatinib	ASTRAZENECA PLC (AZN)
Futibatinib	BRISTOL MYERS SQUIBB CO (BMY)
Futibatinib	PFIZER INC (PFE)
gamunex-c	Grifols S.A. (GRFS)
Golcadomide	Filana Therapeutics Inc. (FLNA)
Golcadomide	Crinetics Pharmaceuticals, Inc. (CRNX)
Golcadomide	Merus N.V. (MRUS)
Golcadomide	ENANTA PHARMACEUTICALS INC (ENTA)
Haematopoietic growth factor	PTC THERAPEUTICS, INC. (PTCT)
hmpl-523	HUTCHMED (China) Ltd (HMDCF)
hmpl-523	HUTCHMED (China) Limited (HCM)
hmpl-689	HUTCHMED (China) Ltd (HMDCF)
hmpl-760	HUTCHMED (China) Ltd (HMDCF)
hmpl-760	HUTCHMED (China) Limited (HCM)
hybryte	SOLIGENIX, INC. (SNGX)
Ibrutinib	Merck & Co., Inc. (MRK)
Idelalisib	ENANTA PHARMACEUTICALS INC (ENTA)
investigator's choice chemotherapy	Genmab A/S (GMAB)
itacitinib	GH Research PLC (GHRS)
kte-c19	Kite Pharma, Inc. (KITE)
lacutamab	GH Research PLC (GHRS)
Larotrectinib	ENANTA PHARMACEUTICALS INC (ENTA)
Larotrectinib Sulfate	ENANTA PHARMACEUTICALS INC (ENTA)
liso-cel	CELGENE CORP /DE/ (CELG)
Liso-cel	BRISTOL MYERS SQUIBB CO (BMY)
lymphodepleting chemotherapy	Novartis AG (NVS)
Lymphodepleting chemotherapy	Novartis AG (NVS)
Mercaptopurine Oral Suspension	Filana Therapeutics Inc. (FLNA)
mosunetuzumab	GH Research PLC (GHRS)
Mosunetuzumab	ENANTA PHARMACEUTICALS INC (ENTA)
navitoclax	AbbVie Inc. (ABBV)
obinutuzumab	GENMAB A/S (GNMSF)
obinutuzumab	BeOne Medicines Ltd. (ONC)
obinutuzumab	Genmab A/S (GMAB)
obinutuzumab	GH Research PLC (GHRS)
Obinutuzumab	ASTRAZENECA PLC (AZN)
Obinutuzumab	BeOne Medicines Ltd. (ONC)
Obinutuzumab	ENANTA PHARMACEUTICALS INC (ENTA)
odronextamab	West Pharmaceutical Services Inc. (WST)
Orelabrutinib	Merus N.V. (MRUS)
Osimertinib	Relay Therapeutics, Inc. (RLAY)
parsaclisib	Incyte Corp. (INCY)
PD -1/PD-L1 monoclonal antibody	ENANTA PHARMACEUTICALS INC (ENTA)
Polatuzumab vedotin	Merck & Co., Inc. (MRK)
Procarbazine Hydrochloride	PTC THERAPEUTICS, INC. (PTCT)
Procarbazine Hydrochloride	Filana Therapeutics Inc. (FLNA)
Procarbazine Hydrochloride	Cosmos Health Inc. (COSM)
r-chop	Incyte Corp. (INCY)
R-CHOP	Filana Therapeutics Inc. (FLNA)
R-CHOP	ASTRAZENECA PLC (AZN)
R-CVP	ASTRAZENECA PLC (AZN)
R-CVP	Merus N.V. (MRUS)
r-gemox	HUTCHMED (China) Ltd (HMDCF)
R-mini-CHOP	ASTRAZENECA PLC (AZN)
Regorafenib	ASTRAZENECA PLC (AZN)
Regorafenib	PFIZER INC (PFE)
Rescue Medication	Merck & Co., Inc. (MRK)
Rocbrutinib	Merus N.V. (MRUS)
rondecabtagene autoleucel	Lyell Immunopharma, Inc. (LYEL)
Sapanisertib	Relay Therapeutics, Inc. (RLAY)
Selinexor	AbbVie Inc. (ABBV)
Selinexor Oral Tablet [Xpovio]	Filana Therapeutics Inc. (FLNA)
Sonrotoclax	ENANTA PHARMACEUTICALS INC (ENTA)
soquelitinib	Corvus Pharmaceuticals, Inc. (CRVS)
soquelitinib (CPI-818)	Corvus Pharmaceuticals, Inc. (CRVS)
standard chemotherapy	Genmab A/S (GMAB)
Surovatamig	Merus N.V. (MRUS)
Surovatamig	ASTRAZENECA PLC (AZN)
tafasitamab	Incyte Corp. (INCY)
tak-007	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
Talazoparib	Novartis AG (NVS)
Talazoparib	Merck & Co., Inc. (MRK)
Taselisib	Relay Therapeutics, Inc. (RLAY)
Temozolomide	BRISTOL MYERS SQUIBB CO (BMY)
Temsirolimus	Merck & Co., Inc. (MRK)
tirabrutinib	Eton Pharmaceuticals, Inc. (ETON)
tirabrutinib	Deciphera Pharmaceuticals, Inc. (DCPH)
tirabrutinib	West Pharmaceutical Services Inc. (WST)
tisagenlecleucel	Novartis AG (NVS)
Tisagenlecleucel	Merus N.V. (MRUS)
tisagenlecleucel after optional bridging	NOVARTIS AG (NVSEF)
tisagenlecleucel after optional bridging	Novartis AG (NVS)
Umbralisib	ASTRAZENECA PLC (AZN)
Vemurafenib and Cobimetinib	ASTRAZENECA PLC (AZN)
Vemurafenib and Cobimetinib	BRISTOL MYERS SQUIBB CO (BMY)
Vemurafenib and Cobimetinib	PFIZER INC (PFE)
Venetoclax	ENANTA PHARMACEUTICALS INC (ENTA)
Venetoclax	ASTRAZENECA PLC (AZN)
venetoclax 10 mg oral tablet [venclexta]	GH Research PLC (GHRS)
venetoclax 100 mg oral tablet [venclexta]	GH Research PLC (GHRS)
venetoclax 50 mg oral tablet [venclexta]	GH Research PLC (GHRS)
vi-0609	VIVUS INC (VVUS)
vinblastine	GH Research PLC (GHRS)
vinblastine	Merck & Co., Inc. (MRK)
Vinblastine	Structure Therapeutics Inc. (GPCR)
Vinblastine Sulfate	Cosmos Health Inc. (COSM)
Vinblastine Sulfate	PTC THERAPEUTICS, INC. (PTCT)
vincristin	GH Research PLC (GHRS)
vincristine	Merck & Co., Inc. (MRK)
vincristine	GH Research PLC (GHRS)
vincristine	Incyte Corp. (INCY)
vincristine	West Pharmaceutical Services Inc. (WST)
vincristine	Genmab A/S (GMAB)
vincristine	REGENERON PHARMACEUTICALS, INC. (REGN)
vincristine	GENMAB A/S (GNMSF)
Vincristine	Crinetics Pharmaceuticals, Inc. (CRNX)
vincristine liposomal	GH Research PLC (GHRS)
Vincristine Sulfate	PTC THERAPEUTICS, INC. (PTCT)
Vincristine Sulfate	Cosmos Health Inc. (COSM)
Zanubrutinib	Merus N.V. (MRUS)
zilovertamab	Oncternal Therapeutics, Inc. (ONCT)
Zilovertamab vedotin	Merck & Co., Inc. (MRK)

Phase 2(273)

Drug	Company
Acetaminophen	Merus N.V. (MRUS)
ACP-196	CYTOKINETICS INC (CYTK)
Adavosertib	Relay Therapeutics, Inc. (RLAY)
Adavosertib	BIOCRYST PHARMACEUTICALS INC (BCRX)
Adavosertib	ADMA BIOLOGICS, INC. (ADMA)
Adavosertib	CURIS INC (CRIS)
ADX-2191	Aldeyra Therapeutics, Inc. (ALDX)
Afatinib	BIOCRYST PHARMACEUTICALS INC (BCRX)
Afatinib	ENANTA PHARMACEUTICALS INC (ENTA)
Afatinib	ADMA BIOLOGICS, INC. (ADMA)
Afatinib	CURIS INC (CRIS)
Afatinib Dimaleate	CURIS INC (CRIS)
Afatinib Dimaleate	ADMA BIOLOGICS, INC. (ADMA)
Afatinib Dimaleate	BIOCRYST PHARMACEUTICALS INC (BCRX)
Afatinib Dimaleate	ENANTA PHARMACEUTICALS INC (ENTA)
ALLO-501	Allogene Therapeutics, Inc. (ALLO)
ALLO-501A	Allogene Therapeutics, Inc. (ALLO)
ALLO-647	Allogene Therapeutics, Inc. (ALLO)
anti-cd20 car-t	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
Axicabtagene Ciloleucel	Filana Therapeutics Inc. (FLNA)
Axicabtagene Ciloleucel	Merus N.V. (MRUS)
Axicabtagene Ciloleucel	PROTHENA CORP PUBLIC LTD CO (PRTA)
Axicabtagene Ciloleucel	Cidara Therapeutics, Inc. (CDTX)
Axicabtagene Ciloleucel	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Axicabtagene Ciloleucel	Structure Therapeutics Inc. (GPCR)
azacitadine	AbbVie Inc. (ABBV)
bendamustine	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
Bendamustine	FATE THERAPEUTICS INC (FATE)
Bendamustine Hydrochloride	FATE THERAPEUTICS INC (FATE)
bicnu	VIVUS INC (VVUS)
Binimetinib	CURIS INC (CRIS)
Binimetinib	ENANTA PHARMACEUTICALS INC (ENTA)
Binimetinib	BIOCRYST PHARMACEUTICALS INC (BCRX)
Binimetinib	ADMA BIOLOGICS, INC. (ADMA)
bleomycin	Merck & Co., Inc. (MRK)
bleomycin	Merus N.V. (MRUS)
bleomycin	GH Research PLC (GHRS)
Bleomycin	FATE THERAPEUTICS INC (FATE)
brentuximab vedotin	GH Research PLC (GHRS)
brentuximab vedotin	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
brentuximab vedotin	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
brentuximab vedotin	PFIZER INC (PFE)
Brentuximab Vedotin	UNITED THERAPEUTICS Corp (UTHR)
Brentuximab Vedotin	FATE THERAPEUTICS INC (FATE)
brexucabtagene autoleucel	GH Research PLC (GHRS)
Brexucabtagene Autoleucel	ELI LILLY & Co (LLY)
bruton's tyrosine kinase inhibitor	GH Research PLC (GHRS)
calcium folinate	Juno Therapeutics, Inc. (JUNO)
Calcium folinate	BRISTOL MYERS SQUIBB CO (BMY)
Calcium folinate	PTC THERAPEUTICS, INC. (PTCT)
Capivasertib	CURIS INC (CRIS)
Capivasertib	ADMA BIOLOGICS, INC. (ADMA)
Capivasertib	BIOCRYST PHARMACEUTICALS INC (BCRX)
CAR T-cells	ADC Therapeutics SA (ADCT)
CAR T-cells	Filana Therapeutics Inc. (FLNA)
cc-99282	Genmab A/S (GMAB)
cc-99282	GENMAB A/S (GNMSF)
CD19 t-haNK- IV Administration	ImmunityBio, Inc. (IBRX)
CD19t-haNK suspension	ImmunityBio, Inc. (IBRX)
cema-cel	Allogene Therapeutics, Inc. (ALLO)
cemacabtagene ansegedleucel	Allogene Therapeutics, Inc. (ALLO)
chimeric antigen receptor t-cell therapy	GH Research PLC (GHRS)
CLLS52	Cellectis S.A. (CLLS)
cnct19	CASI Pharmaceuticals, Inc (DE) (CASI)
Copanlisib	BIOCRYST PHARMACEUTICALS INC (BCRX)
Copanlisib	ADMA BIOLOGICS, INC. (ADMA)
Copanlisib	Relay Therapeutics, Inc. (RLAY)
Copanlisib	CURIS INC (CRIS)
Copanlisib Hydrochloride	CURIS INC (CRIS)
Copanlisib Hydrochloride	ADMA BIOLOGICS, INC. (ADMA)
Copanlisib Hydrochloride	BIOCRYST PHARMACEUTICALS INC (BCRX)
Crizotinib	ADMA BIOLOGICS, INC. (ADMA)
Crizotinib	BIOCRYST PHARMACEUTICALS INC (BCRX)
Crizotinib	Relay Therapeutics, Inc. (RLAY)
Crizotinib	CURIS INC (CRIS)
Cyclophophamide	Allogene Therapeutics, Inc. (ALLO)
cyt-0851	Cyteir Therapeutics, Inc. (CYT)
Cytarabine	FATE THERAPEUTICS INC (FATE)
Dabrafenib	CURIS INC (CRIS)
Dabrafenib	Relay Therapeutics, Inc. (RLAY)
Dabrafenib	BIOCRYST PHARMACEUTICALS INC (BCRX)
Dabrafenib	ADMA BIOLOGICS, INC. (ADMA)
Dabrafenib Mesylate	Relay Therapeutics, Inc. (RLAY)
Dabrafenib Mesylate	ADMA BIOLOGICS, INC. (ADMA)
Dabrafenib Mesylate	BIOCRYST PHARMACEUTICALS INC (BCRX)
Dabrafenib Mesylate	CURIS INC (CRIS)
Dabrafenib plus Trametinib	Merck & Co., Inc. (MRK)
Dabrafenib plus Trametinib	ELI LILLY & Co (LLY)
dacarbazine	Merck & Co., Inc. (MRK)
Dacarbazine	UNITED THERAPEUTICS Corp (UTHR)
Daratumumab SC	FATE THERAPEUTICS INC (FATE)
Dasatinib	CURIS INC (CRIS)
Dasatinib	Relay Therapeutics, Inc. (RLAY)
Dasatinib	BIOCRYST PHARMACEUTICALS INC (BCRX)
Dasatinib	ADMA BIOLOGICS, INC. (ADMA)
Defactinib	Relay Therapeutics, Inc. (RLAY)
Defactinib	ADMA BIOLOGICS, INC. (ADMA)
Defactinib	BIOCRYST PHARMACEUTICALS INC (BCRX)
Defactinib	CURIS INC (CRIS)
Defactinib Hydrochloride	CURIS INC (CRIS)
Defactinib Hydrochloride	BIOCRYST PHARMACEUTICALS INC (BCRX)
Defactinib Hydrochloride	ADMA BIOLOGICS, INC. (ADMA)
Diphenhydramine	Cidara Therapeutics, Inc. (CDTX)
Diphenhydramine	PROTHENA CORP PUBLIC LTD CO (PRTA)
Diphenhydramine	Filana Therapeutics Inc. (FLNA)
Diphenhydramine	Merus N.V. (MRUS)
dtic	GH Research PLC (GHRS)
DTIC	FATE THERAPEUTICS INC (FATE)
dzd8586	NYMOX PHARMACEUTICAL CORP (NYMXF)
Enfortumab vedotin	UNITED THERAPEUTICS Corp (UTHR)
Epcoritamab	AbbVie Inc. (ABBV)
Erdafitinib	ENANTA PHARMACEUTICALS INC (ENTA)
Erdafitinib	ADMA BIOLOGICS, INC. (ADMA)
Erdafitinib	BIOCRYST PHARMACEUTICALS INC (BCRX)
Erdafitinib	Relay Therapeutics, Inc. (RLAY)
Erdafitinib	CURIS INC (CRIS)
Etoposide	Merck & Co., Inc. (MRK)
Etoposide	ADC Therapeutics SA (ADCT)
Etoposide	FATE THERAPEUTICS INC (FATE)
Etoposide Phosphate	ADC Therapeutics SA (ADCT)
Fexagratinib	CURIS INC (CRIS)
Fexagratinib	ADMA BIOLOGICS, INC. (ADMA)
Fexagratinib	Relay Therapeutics, Inc. (RLAY)
Fexagratinib	BIOCRYST PHARMACEUTICALS INC (BCRX)
Fexagratinib	ENANTA PHARMACEUTICALS INC (ENTA)
Filgrastim	FATE THERAPEUTICS INC (FATE)
Fludarabine	PTC THERAPEUTICS, INC. (PTCT)
Fludarabine	Allogene Therapeutics, Inc. (ALLO)
Fludarabine	FATE THERAPEUTICS INC (FATE)
Fludarabine phosphate	PROTHENA CORP PUBLIC LTD CO (PRTA)
Fludarabine phosphate	Cidara Therapeutics, Inc. (CDTX)
Fludarabine phosphate	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
fs118	F-star Therapeutics, Inc. (FSTX)
FT819	FATE THERAPEUTICS INC (FATE)
Futibatinib	ELI LILLY & Co (LLY)
Futibatinib	ENANTA PHARMACEUTICALS INC (ENTA)
g100	IMMUNE DESIGN CORP. (IMDZ)
golcadomide	GH Research PLC (GHRS)
Golidocitinib	Filana Therapeutics Inc. (FLNA)
haNK	ImmunityBio, Inc. (IBRX)
hypericin	SOLIGENIX, INC. (SNGX)
Ibrutinib	ENANTA PHARMACEUTICALS INC (ENTA)
Ibrutinib	Filana Therapeutics Inc. (FLNA)
Ibrutinib	Crinetics Pharmaceuticals, Inc. (CRNX)
Ibrutinib	Merus N.V. (MRUS)
Ifosfamide	ADC Therapeutics SA (ADCT)
Ifosfamide	ENANTA PHARMACEUTICALS INC (ENTA)
impt-314	Lyell Immunopharma, Inc. (LYEL)
Ipatasertib	BIOCRYST PHARMACEUTICALS INC (BCRX)
Ipatasertib	ADMA BIOLOGICS, INC. (ADMA)
Ipatasertib	CURIS INC (CRIS)
iph4102	Innate Pharma SA (IPHYF)
iph4102	Innate Pharma S.A. (IPHA)
iph6501	Innate Pharma S.A. (IPHA)
jnj-95566692	GH Research PLC (GHRS)
Larotrectinib	CURIS INC (CRIS)
Larotrectinib	Relay Therapeutics, Inc. (RLAY)
Larotrectinib	ADMA BIOLOGICS, INC. (ADMA)
Larotrectinib	BIOCRYST PHARMACEUTICALS INC (BCRX)
Larotrectinib Sulfate	ADMA BIOLOGICS, INC. (ADMA)
Larotrectinib Sulfate	BIOCRYST PHARMACEUTICALS INC (BCRX)
Larotrectinib Sulfate	CURIS INC (CRIS)
liso-cel	Juno Therapeutics, Inc. (JUNO)
Liso-cel	PTC THERAPEUTICS, INC. (PTCT)
Loncastuximab tesirine	Filana Therapeutics Inc. (FLNA)
Loncastuximab tesirine	ENANTA PHARMACEUTICALS INC (ENTA)
Loncastuximab Tesirine and Epcoritamab	AbbVie Inc. (ABBV)
mb-cart2019.1	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
mechlorethamine	SOLIGENIX, INC. (SNGX)
Mivavotinib (CB-659, formerly TAK-659)	Calithera Biosciences, Inc. (CALA)
Mivavotinib (CB-659)	Calithera Biosciences, Inc. (CALA)
Mosunetuzumab	Crinetics Pharmaceuticals, Inc. (CRNX)
mt-601	Marker Therapeutics, Inc. (MRKR)
n803 plus bacillus calmette-guerin	ImmunityBio, Inc. (IBRX)
Nilotinib Hydrochloride Monohydrate	ADMA BIOLOGICS, INC. (ADMA)
Obinutuzumab	CYTOKINETICS INC (CYTK)
Obinutuzumab	FATE THERAPEUTICS INC (FATE)
Obinutuzumab	Merus N.V. (MRUS)
Odronextamab	Filana Therapeutics Inc. (FLNA)
Odronextamab	ADC Therapeutics SA (ADCT)
Odronextamab	ENANTA PHARMACEUTICALS INC (ENTA)
Olaparib	ELI LILLY & Co (LLY)
Olaparib	PFIZER INC (PFE)
Olaparib	BRISTOL MYERS SQUIBB CO (BMY)
Orelabrutinib	ENANTA PHARMACEUTICALS INC (ENTA)
Orelabrutinib combined with obinutuzumab	FATE THERAPEUTICS INC (FATE)
Osimertinib	CURIS INC (CRIS)
Osimertinib	BIOCRYST PHARMACEUTICALS INC (BCRX)
Osimertinib	ADMA BIOLOGICS, INC. (ADMA)
Pertuzumab	Relay Therapeutics, Inc. (RLAY)
Pertuzumab	ADMA BIOLOGICS, INC. (ADMA)
Pertuzumab	BIOCRYST PHARMACEUTICALS INC (BCRX)
Pertuzumab	CURIS INC (CRIS)
PI3K-beta Inhibitor GSK2636771	CURIS INC (CRIS)
PI3K-beta Inhibitor GSK2636771	BIOCRYST PHARMACEUTICALS INC (BCRX)
PI3K-beta Inhibitor GSK2636771	ADMA BIOLOGICS, INC. (ADMA)
polatuzumab vedotin	GENMAB A/S (GNMSF)
polatuzumab vedotin	Genmab A/S (GMAB)
polatuzumab vedotin	GH Research PLC (GHRS)
Pomalidomide	ENANTA PHARMACEUTICALS INC (ENTA)
prizloncabtagene autoleucel	GH Research PLC (GHRS)
procarbazine	Juno Therapeutics, Inc. (JUNO)
Procarbazine	BRISTOL MYERS SQUIBB CO (BMY)
Procarbazine	PTC THERAPEUTICS, INC. (PTCT)
R-CHOP Protocol	Filana Therapeutics Inc. (FLNA)
R-CHOP Protocol	ENANTA PHARMACEUTICALS INC (ENTA)
r-gemox	HUTCHMED (China) Limited (HCM)
Regorafenib	Novartis AG (NVS)
Regorafenib	ELI LILLY & Co (LLY)
Regorafenib	Merck & Co., Inc. (MRK)
Relatlimab	CURIS INC (CRIS)
Relatlimab	Relay Therapeutics, Inc. (RLAY)
Relatlimab	ADMA BIOLOGICS, INC. (ADMA)
Relatlimab	BIOCRYST PHARMACEUTICALS INC (BCRX)
rocbrutinib	NYMOX PHARMACEUTICAL CORP (NYMXF)
Sapanisertib	CURIS INC (CRIS)
Sapanisertib	ENANTA PHARMACEUTICALS INC (ENTA)
Sapanisertib	BIOCRYST PHARMACEUTICALS INC (BCRX)
Sapanisertib	ADMA BIOLOGICS, INC. (ADMA)
Selumetinib Sulfate	ADMA BIOLOGICS, INC. (ADMA)
Sonrotoclax	FATE THERAPEUTICS INC (FATE)
t-haNK	ImmunityBio, Inc. (IBRX)
tafasitamab	GH Research PLC (GHRS)
Tafasitamab	ENANTA PHARMACEUTICALS INC (ENTA)
Talazoparib	BRISTOL MYERS SQUIBB CO (BMY)
Talazoparib	ENANTA PHARMACEUTICALS INC (ENTA)
Talazoparib	ELI LILLY & Co (LLY)
Talimogene Laherparepvec	ENANTA PHARMACEUTICALS INC (ENTA)
Taselisib	BIOCRYST PHARMACEUTICALS INC (BCRX)
Taselisib	ADMA BIOLOGICS, INC. (ADMA)
Taselisib	ENANTA PHARMACEUTICALS INC (ENTA)
Taselisib	CURIS INC (CRIS)
tazemetostat	GH Research PLC (GHRS)
Tazemetostat	FATE THERAPEUTICS INC (FATE)
tazverik	Epizyme, Inc. (EPZM)
Temozolomide	Merck & Co., Inc. (MRK)
Temsirolimus	PFIZER INC (PFE)
Temsirolimus	BRISTOL MYERS SQUIBB CO (BMY)
tipifarnib	Kura Oncology, Inc. (KURA)
Tisagenlecleucel	Novartis AG (NVS)
Tocilizumab	Filana Therapeutics Inc. (FLNA)
Trametinib	CURIS INC (CRIS)
Trametinib	ADMA BIOLOGICS, INC. (ADMA)
Trametinib	Relay Therapeutics, Inc. (RLAY)
Trametinib	BIOCRYST PHARMACEUTICALS INC (BCRX)
UCART20x22	Cellectis S.A. (CLLS)
Ulixertinib	Relay Therapeutics, Inc. (RLAY)
Ulixertinib	ADMA BIOLOGICS, INC. (ADMA)
Ulixertinib	ENANTA PHARMACEUTICALS INC (ENTA)
Ulixertinib	BIOCRYST PHARMACEUTICALS INC (BCRX)
Ulixertinib	CURIS INC (CRIS)
Umbralisib	Filana Therapeutics Inc. (FLNA)
Umbralisib	FATE THERAPEUTICS INC (FATE)
Umbralisib	Merus N.V. (MRUS)
Vemurafenib and Cobimetinib	Merck & Co., Inc. (MRK)
Vemurafenib and Cobimetinib	ELI LILLY & Co (LLY)
Vemurafenib and Cobimetinib	Novartis AG (NVS)
Vemurafenib and Cobimetinib	ENANTA PHARMACEUTICALS INC (ENTA)
Venetoclax	CYTOKINETICS INC (CYTK)
Venetoclax	ELI LILLY & Co (LLY)
Venetoclax	Filana Therapeutics Inc. (FLNA)
Vinblastine	FATE THERAPEUTICS INC (FATE)
Vinblastine	UNITED THERAPEUTICS Corp (UTHR)
Vinblastine Sulfate	ADMA BIOLOGICS, INC. (ADMA)
Vincristine	FATE THERAPEUTICS INC (FATE)
Vincristine Sulfate	FATE THERAPEUTICS INC (FATE)
Vismodegib	CURIS INC (CRIS)
Vismodegib	Relay Therapeutics, Inc. (RLAY)
Vismodegib	BIOCRYST PHARMACEUTICALS INC (BCRX)
Vismodegib	ENANTA PHARMACEUTICALS INC (ENTA)
Vismodegib	ADMA BIOLOGICS, INC. (ADMA)
Zanubrutinib	ENANTA PHARMACEUTICALS INC (ENTA)
Zanubrutinib	FATE THERAPEUTICS INC (FATE)

Phase 1(104)

Drug	Company
[14C]ABT-199	AbbVie Inc. (ABBV)
abatacept	Merus N.V. (MRUS)
ABBV-525	AbbVie Inc. (ABBV)
ABT-199	AbbVie Inc. (ABBV)
ace1831	IO Biotech, Inc. (IOBT)
ADI-001	Adicet Bio, Inc. (ACET)
anti-cd19 car-based product candidate	Kite Pharma, Inc. (KITE)
ARV-393	ARVINAS, INC. (ARVN)
ATA3219	Atara Biotherapeutics, Inc. (ATRA)
Autologous BAFFR-targeting CAR T Cells	Filana Therapeutics Inc. (FLNA)
bendamustine	AbbVie Inc. (ABBV)
Bendamustine	Filana Therapeutics Inc. (FLNA)
BET Bromodomain Inhibitor ZEN-3694	ADMA BIOLOGICS, INC. (ADMA)
Bleomycin	ENANTA PHARMACEUTICALS INC (ENTA)
Bleomycin	PTC THERAPEUTICS, INC. (PTCT)
BP1002	BIO-PATH HOLDINGS, INC. (BPTH)
Bridging Therapy	Filana Therapeutics Inc. (FLNA)
BZ019	Merus N.V. (MRUS)
BZ019	Filana Therapeutics Inc. (FLNA)
CB-010	Caribou Biosciences, Inc. (CRBU)
cc-122	BRISTOL MYERS SQUIBB CO (BMY)
CC-99282	ENANTA PHARMACEUTICALS INC (ENTA)
cd19 t-hank	ImmunityBio, Inc. (IBRX)
CD19-CD34t metabolically programmed CAR transduced T-cells	Filana Therapeutics Inc. (FLNA)
cd19t-hank	ImmunityBio, Inc. (IBRX)
Copanlisib	ENANTA PHARMACEUTICALS INC (ENTA)
Crizotinib	ENANTA PHARMACEUTICALS INC (ENTA)
CTX-8371	Compass Therapeutics, Inc. (CMPX)
CTX112	CRISPR Therapeutics AG (CRSP)
CTX131	CRISPR Therapeutics AG (CRSP)
Cytarabine	Black Diamond Therapeutics, Inc. (BDTX)
duet-01	Scopus BioPharma Inc. (SCPS)
duvelisib	AbbVie Inc. (ABBV)
E7777 (LYMPHIR) prior to CAR-T	CITIUS ONCOLOGY, INC. (CTOR)
epcoritamab	Genmab A/S (GMAB)
epcoritamab	Genmab A/S (GMAB)
exoil-12	Codiak BioSciences, Inc. (CDAK)
fludarabine	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
fludarabine	IO Biotech, Inc. (IOBT)
Fludarabine	ImmunityBio, Inc. (IBRX)
FT522	FATE THERAPEUTICS INC (FATE)
gazyvaro	Incyte Corp. (INCY)
hexal	Incyte Corp. (INCY)
Ibrutinib	Black Diamond Therapeutics, Inc. (BDTX)
IL-2	FATE THERAPEUTICS INC (FATE)
Isavuconazole	Black Diamond Therapeutics, Inc. (BDTX)
Isavuconazole	ENANTA PHARMACEUTICALS INC (ENTA)
jcar017	Juno Therapeutics, Inc. (JUNO)
JCAR017 + ibrutinib	Merus N.V. (MRUS)
jnj-87801493	GH Research PLC (GHRS)
jnj-88998377	GH Research PLC (GHRS)
jnj-90009530	GH Research PLC (GHRS)
Ketoconazole	AbbVie Inc. (ABBV)
KRAS TCR-Transduced PBL	Filana Therapeutics Inc. (FLNA)
KT-253	Kymera Therapeutics, Inc. (KYMR)
KT-333	Kymera Therapeutics, Inc. (KYMR)
kur-502	Athenex, Inc. (ATNX)
Lisaftoclax	Filana Therapeutics Inc. (FLNA)
Loncastuximab tesirine	ADC Therapeutics SA (ADCT)
LY4152199 - IV	ELI LILLY & Co (LLY)
LY4584180	ELI LILLY & Co (LLY)
LYMPHIR (investigator-initiated: pre-CAR-T)	CITIUS ONCOLOGY, INC. (CTOR)
mb-106	MUSTANG BIO, INC. (MBIO)
mb-cart2019.1 dose level 1	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
mb-cart2019.1 dose level 2	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
Mogamulizumab	Filana Therapeutics Inc. (FLNA)
mosunetuzumab	ADC Therapeutics SA (ADCT)
N803	ImmunityBio, Inc. (IBRX)
Natural Killer Cell Therapy	Filana Therapeutics Inc. (FLNA)
NX-5948	Nurix Therapeutics, Inc. (NRIX)
obinutuzumab	ADC Therapeutics SA (ADCT)
obinutuzumab	IO Biotech, Inc. (IOBT)
odronextamab	REGENERON PHARMACEUTICALS, INC. (REGN)
p-cd19cd20-allo1	Poseida Therapeutics, Inc. (PSTX)
pf-08046045	PFIZER INC (PFE)
pic1	PRECISION BIOSCIENCES INC (DTIL)
pit565	Novartis AG (NVS)
pit565	Novartis AG (NVS)
plogosertib (plogo)	Bio Green Med Solution, Inc. (BGMSP)
POLA-R-CHP	Filana Therapeutics Inc. (FLNA)
polatuzumab vedotin	ADC Therapeutics SA (ADCT)
prt2527	Prelude Therapeutics Inc (PRLD)
Recombinant human interleukin-15	ENANTA PHARMACEUTICALS INC (ENTA)
regn5837	REGENERON PHARMACEUTICALS, INC. (REGN)
Rifampin	AbbVie Inc. (ABBV)
rimiducid	Poseida Therapeutics, Inc. (PSTX)
roginolisib	Merus N.V. (MRUS)
sar448501	Sanofi (SNY)
sc262	Sana Biotechnology, Inc. (SANA)
sc291	Sana Biotechnology, Inc. (SANA)
sgr-1505	Schrodinger, Inc. (SDGR)
tazemetostat	Epizyme, Inc. (EPZM)
Tazemetostat	ENANTA PHARMACEUTICALS INC (ENTA)
TEDD	ENANTA PHARMACEUTICALS INC (ENTA)
TEDD	Black Diamond Therapeutics, Inc. (BDTX)
TEDDI	Black Diamond Therapeutics, Inc. (BDTX)
TEDDI	ENANTA PHARMACEUTICALS INC (ENTA)
Temozolomide	ADMA BIOLOGICS, INC. (ADMA)
tti-622	Trillium Therapeutics Inc. (TRIL)
Valemetostat	ENANTA PHARMACEUTICALS INC (ENTA)
Veliparib	Filana Therapeutics Inc. (FLNA)
vispa-cel	Caribou Biosciences, Inc. (CRBU)
Vorinostat	Merus N.V. (MRUS)
zamtocabtagene autoleucel	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)

Preclinical(4)

Drug	Company
hicar-t	Orgenesis Inc. (ORGS)
inb-600	IN8BIO, INC. (INAB)
km10544	Emmaus Life Sciences, Inc. (EMMA)
zandelisib	Lite Strategy, Inc. (LITS)

Unknown(3)

Drug	Company
b-cell lymphoma 2 protein inhibitor	GH Research PLC (GHRS)
Bleomycin Sulfate	ENANTA PHARMACEUTICALS INC (ENTA)
caribou-sponsored investigational therapy	Caribou Biosciences, Inc. (CRBU)

Phase 1/Phase 2(36)

Drug	Company
ab-101	Artiva Biotherapeutics, Inc. (ARTV)
abexinostat	XYNOMIC PHARMACEUTICALS HOLDINGS, INC. (BCACU)
anti-cd19 car t-cells	GH Research PLC (GHRS)
AUTO4	Autolus Therapeutics plc (AUTL)
AUTO5	Autolus Therapeutics plc (AUTL)
bendamustine	Karyopharm Therapeutics Inc. (KPTI)
bendamustine	Artiva Biotherapeutics, Inc. (ARTV)
cemiplimab regn2810	Sanofi (SNY)
cho-h01	CHINA PHARMA HOLDINGS, INC. (CPHI)
cho-h01 at rp2d	CHINA PHARMA HOLDINGS, INC. (CPHI)
eb103	ESTRELLA IMMUNOPHARMA, INC. (UPTD)
eb103	Estrella Immunopharma Inc. (ESLA)
Fimepinostat	CURIS INC (CRIS)
fludarabine	Lyell Immunopharma, Inc. (LYEL)
fludarabine	Artiva Biotherapeutics, Inc. (ARTV)
gen3017	GENMAB A/S (GNMSF)
gen3017	Genmab A/S (GMAB)
glpg5101	Galapagos NV (GLPG)
GLPG5101	Galapagos NV (GLPG)
hem101	GH Research PLC (GHRS)
interleukin-2	Artiva Biotherapeutics, Inc. (ARTV)
iph6501	Innate Pharma SA (IPHYF)
isatuximab sar650984	Sanofi (SNY)
isatuximab SAR650984	Sanofi (SNY)
lyl314	Lyell Immunopharma, Inc. (LYEL)
maplirpacept	PFIZER INC (PFE)
miransertib	ARQULE INC (ARQL)
Mosunetuzumab	BRISTOL MYERS SQUIBB CO (BMY)
Nemtabrutinib	Merck & Co., Inc. (MRK)
obinutuzumab	Nurix Therapeutics, Inc. (NRIX)
onct-808	Oncternal Therapeutics, Inc. (ONCT)
polatuzumab vedotin	Karyopharm Therapeutics Inc. (KPTI)
reduced-dose hht	CHINA PHARMA HOLDINGS, INC. (CPHI)
standard-dose hht	CHINA PHARMA HOLDINGS, INC. (CPHI)
tafasitamab	Karyopharm Therapeutics Inc. (KPTI)
tafasitamab	PFIZER INC (PFE)

Phase 2/Phase 3(4)

Drug	Company
asparaginase erwinia chrysanthemi	GH Research PLC (GHRS)
bendamustine	Incyte Corp. (INCY)
copad	GH Research PLC (GHRS)
ifx-3.0	TuHURA Biosciences, Inc./NV (HURA)

Phase 4(35)

Drug	Company
Acalabrutinib monotherapy	ASTRAZENECA PLC (AZN)
Acetaminophen	Filana Therapeutics Inc. (FLNA)
anti-vascular endothelial growth factor	GH Research PLC (GHRS)
bms-986369	BRISTOL MYERS SQUIBB CO (BMY)
BMS-986458	BRISTOL MYERS SQUIBB CO (BMY)
brentuximab vedotin	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
Brentuximab Vedotin	PTC THERAPEUTICS, INC. (PTCT)
Brentuximab Vedotin	Merus N.V. (MRUS)
Cytarabine	Filana Therapeutics Inc. (FLNA)
Dacarbazine	Merus N.V. (MRUS)
Daunorubicin Hydrochloride	Filana Therapeutics Inc. (FLNA)
Etoposide	Filana Therapeutics Inc. (FLNA)
Etoposide Phosphate	Filana Therapeutics Inc. (FLNA)
Futibatinib	Novartis AG (NVS)
ibrutinib	Incyte Corp. (INCY)
Induction therapy	Filana Therapeutics Inc. (FLNA)
mogamulizumab	NYMOX PHARMACEUTICAL CORP (NYMXF)
Pomalidomide	Filana Therapeutics Inc. (FLNA)
Ponatinib Hydrochloride	Filana Therapeutics Inc. (FLNA)
Relatlimab	BRISTOL MYERS SQUIBB CO (BMY)
Talazoparib	ASTRAZENECA PLC (AZN)
Temsirolimus	Novartis AG (NVS)
Thalidomide	Filana Therapeutics Inc. (FLNA)
Tislelizumab	ENANTA PHARMACEUTICALS INC (ENTA)
Venetoclax	AbbVie Inc. (ABBV)
vinblastine	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
vinblastine	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
Vinblastine	Merus N.V. (MRUS)
Vinblastine	PTC THERAPEUTICS, INC. (PTCT)
Vinblastine	ENANTA PHARMACEUTICALS INC (ENTA)
Vinblastine Sulfate	Filana Therapeutics Inc. (FLNA)
Vincristine	Filana Therapeutics Inc. (FLNA)
Vincristine Sulfate	Filana Therapeutics Inc. (FLNA)
Vincristine Sulfate Liposome	Filana Therapeutics Inc. (FLNA)
Zanubrutinib	BeOne Medicines Ltd. (ONC)

Compare drugs

Alimta® vs belrapzo Alimta® vs bexarotene Alimta® vs bortezomib

Frequently asked questions

How many drugs are in development for Lymphoma?

BioSniper tracks 668 drugs in development for Lymphoma across 118 companies.

How many clinical trials target Lymphoma?

There are 58 clinical trials targeting Lymphoma tracked by BioSniper.

What is the prevalence of Lymphoma?

The estimated prevalence of Lymphoma is approximately 56.0 per 100,000 population.

Deep-dive into Lymphoma

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis